DR. HARI NADIMINTI M.D. NPI 1558520700

NPI Details

DR. Hari Nadiminti, M.D. is a dermatology in Berkeley Heights, NJ with 21 years of experience. The provider is a dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging. DR. Hari Nadiminti, M.D. NPI is 1558520700. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF MIAMI, LM MILLER SCHOOL OF MEDICINE
Graduation Year:2005

The provider's business location address is:

1 DIAMOND HILL RD
BERKELEY HEIGHTS, NJ
ZIP 07922-104
Phone: (908) 277-8668
Fax: (908) 277-8629

The NPI 1558520700 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks (HCPCS:17311)
• Destruction of precancer skin growth, 2-14 growths (HCPCS:17003)
• Biopsy of related skin growth, first growth (HCPCS:11102)
• Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg (HCPCS:J7345)
• Destruction of precancer skin growth, 1 growth (HCPCS:17000)
• Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks (HCPCS:17312)
• Biopsy of related skin growth, each additional growth (HCPCS:11103)
• Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
• Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks (HCPCS:17313)
• Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm (HCPCS:11602)
• Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm (HCPCS:12032)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm (HCPCS:13132)
• Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm (HCPCS:13121)
• Application of light with debridement to destroy precancer skin growth (HCPCS:96574)
• New patient office or other outpatient visit, 15-29 minutes (HCPCS:99202)
• Removal and microscopic exam of growth of trunk, arms, or legs, each additional stage, 1-5 tissue blocks (HCPCS:17314)
• Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) (HCPCS:J7308)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Destruction of skin growth, 1-14 growths (HCPCS:17110)
• Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm (HCPCS:17261)
• Complicated repair of wound of trunk, 2.6-7.5 cm (HCPCS:13101)
• Biopsy of ear (HCPCS:69100)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Complicated repair of wound of eyelids, nose, ears, or lip, 2.6-7.5 cm (HCPCS:13152)
• Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm (HCPCS:11402)
• Special stained specimen slides to examine tissue, initial procedure (HCPCS:88342)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm (HCPCS:11603)
• Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 1.1-2.5 cm (HCPCS:13131)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 6/3/2008 and was last updated on 8/15/2019.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: